-
公开(公告)号：US20230165521A1
公开(公告)日：2023-06-01
申请号：US17919267
申请日：2021-04-14
Inventor： Noam SOBEL , Anat ARZI , Liron ROZENKRANTZ , Lior GORODISKY , Yael HOLTZMAN , Yaron SACHER , Danit ROZENKRANTZ
CPC classification number: A61B5/4842 , A61B5/091 , A61B5/0816 , A61B5/4011
Abstract: A method of assessing a subject including: measuring a plurality of respirations of the subject; determining one or more respiration parameter from the plurality of respirations; and determining, using the one or more respiration parameter, one or more of: a state of consciousness of the subject; and a prognosis of the subject.
-
公开(公告)号：US11638642B2
公开(公告)日：2023-05-02
申请号：US16483752
申请日：2018-03-01
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor： Gonen Omer , Ori Mahler
Abstract: Embodiments concern an intraocular implantable device operable comprising a disk-shaped body having a symmetry axis and which further comprises a light-transmissive portion and an opaque portion wherein the light-transmissive portion is decentered with respect to the symmetry axis.
-
公开(公告)号：US20230125981A1
公开(公告)日：2023-04-27
申请号：US17906243
申请日：2021-03-18
Inventor： Yaniv SHILO , Brian BERKOWITZ
Abstract: Embodiments pertain to ureteral stents for treatment of partial or full ureteral occlusion by bridging one or more ureteral occlusions, where each stent includes a tubular portion, a first spout portion and a second spout portion. The stent may have one or more tapered edges by having the smallest diameter of the first and/or the second spout portion smaller than the largest diameter of the tubular portion, and/or be of an overall length allowing the ureteral stent to be completely located within a patient's ureter once deployed therein.
-
公开(公告)号：US20230023026A1
公开(公告)日：2023-01-26
申请号：US17758422
申请日：2021-01-06
Applicant: Mor Research Applications Ltd.
Inventor： Orith Waisbourd-Zinman
IPC: A61K31/198 , A61K31/385 , A61K31/593 , A61K31/26 , A61K31/7076 , A61P1/16
Abstract: Methods of treating damaged bile ducts by way of elevating glutathione (GSH) levels, restoring normal GSH levels, and/or maintaining normal GSH levels in the biliary ducts are disclosed. A disclosed method comprises local treatment of damaged biliary ducts, e.g., by directly delivering to the bile ducts lumen of at least one active agent that promotes increasing of GSH production or inhibiting of GSH degradation in the biliary epithelial cells.
-
公开(公告)号：US11519914B2
公开(公告)日：2022-12-06
申请号：US16480342
申请日：2018-01-25
Inventor： Esther Rabizadeh
IPC: G01N33/86 , G01N33/574
Abstract: A method for diagnosing a malignant proliferative disease or disorder in a subject, and/or for following up, monitoring or prognosticating the therapy of a malignant proliferative disease or disorder in a subject is disclosed. The method is based on measurement of platelet-mediated fibrinogen-like protein 2 (FGL2) activity in a sample essentially comprising platelets obtained from the subject. In accordance with the disclosed method, platelet-mediated FGL2 activity level higher than control is indicative of the presence of a malignant proliferative disease or disorder in a subject.
-
Patent Agency Ranking
公开(公告)号：US11241244B2
公开(公告)日：2022-02-08
申请号：US15962285
申请日：2018-04-25
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor： Ronen Jaffe , Eytan Jaffe
IPC: A61B17/221 , A61B17/22 , A61M25/10
Abstract: A catheter for removable insertion into a body vasculature has at least one inflatable member. The catheter has at least in part an expandable body that forms an internal axially extending lumen in at least the expanded state of the body. The inflatable member is adjacent a distal axial end of the body and is configured to at least partially obstruct the lumen.
-
77.发明授权公开(公告)号：US11081235B2
公开(公告)日：2021-08-03
申请号：US16432212
申请日：2019-06-05
Inventor： Michal A. Rahat , Nitza Lahat , Miriam Walter , Haim Bitterman
IPC: A61K39/00 , G16H50/30 , C07K16/28 , C07K14/705 , C12N15/62 , G01N33/574 , C07K14/435 , C07K7/06 , C07K7/08 , G01N33/68 , A61K38/00
Abstract: The invention provides isolated peptides from the protein EMMPRIN (CD147/Basigin) and antibodies directed against antigenic determinants within said peptides. Pharmaceutical compositions comprising said peptides and antibodies are also disclosed as well as methods of their production and use in vaccination, immunotherapy and diagnosis of proliferative, hyperpermeability, inflammatory, and angiogenesis-related diseases and disorders.
-
公开(公告)号：US20210206834A1
公开(公告)日：2021-07-08
申请号：US17154864
申请日：2021-01-21
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor： Dov WEINBERGER , Tami LIVNAT , Yael NISGAV
IPC: C07K14/745 , A61P27/02 , A61K45/06
Abstract: Methods for treating and/or preventing choroidal neovascularization (CNV) or retinal leakage associated with CNV are disclosed, comprising the use of activated protein C (APC) and/or an APC variant. A disclosed method may be applied in the treatment or prevention of ocular diseases, disorders or conditions that are caused directly by CVN, feature development of CNV as a secondary stage or a complication thereof, and/or feature CNV as a synchronous or asynchronous sequela thereof. An exemplary disease treatable by a disclosed method is neovascular age-related macular degeneration (nAMD).
-
公开(公告)号：US10952903B2
公开(公告)日：2021-03-23
申请号：US15911895
申请日：2018-03-05
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor： Ariel Margulis
Abstract: A method for repairing a perforation in a tympanic membrane comprising attaching a single patch to an undersurface of the tympanic membrane covering the perforation.
-
公开(公告)号：US20200261405A1
公开(公告)日：2020-08-20
申请号：US16756575
申请日：2018-10-18
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor： Noach BEN-SHALOM , Dror ROBINSON
Abstract: The present invention provides a composition based on cannabidiol (CBD) and chitosan for use in reducing blood cholesterol, blood LDL and blood triglycerides levels.
-
-
-
-
-
-
-
-
-
Search Results
158
records
(took 0.023 seconds)
